AU1382595A - Factor viii derivatives - Google Patents

Factor viii derivatives

Info

Publication number
AU1382595A
AU1382595A AU13825/95A AU1382595A AU1382595A AU 1382595 A AU1382595 A AU 1382595A AU 13825/95 A AU13825/95 A AU 13825/95A AU 1382595 A AU1382595 A AU 1382595A AU 1382595 A AU1382595 A AU 1382595A
Authority
AU
Australia
Prior art keywords
factor viii
viii derivatives
derivatives
factor
viii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13825/95A
Inventor
Mirella Ezban Rasmussen
Else Marie Nicolaisen
Egon Persson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU1382595A publication Critical patent/AU1382595A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU13825/95A 1994-01-07 1995-01-06 Factor viii derivatives Abandoned AU1382595A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK3294 1994-01-07
DK00032/94 1994-01-07
PCT/DK1995/000008 WO1995018827A1 (en) 1994-01-07 1995-01-06 Factor viii derivatives

Publications (1)

Publication Number Publication Date
AU1382595A true AU1382595A (en) 1995-08-01

Family

ID=8088981

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13825/95A Abandoned AU1382595A (en) 1994-01-07 1995-01-06 Factor viii derivatives

Country Status (2)

Country Link
AU (1) AU1382595A (en)
WO (1) WO1995018827A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5910481A (en) * 1995-11-13 1999-06-08 Immuno Ag Hybrid proteins with modified activity
AT403438B (en) * 1996-05-24 1998-02-25 Immuno Ag PHARMACEUTICAL PREPARATION WITH FACTOR VIII PROCOAGULATION ACTIVITY AND VWF BINDING ACTIVITY
AU5282200A (en) * 1999-05-24 2000-12-12 American National Red Cross, The Methods of reducing factor viii clearance and compositions therefor
CA2434097A1 (en) * 2001-01-12 2002-08-08 The American National Red Cross Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor viii
EP1424344A1 (en) * 2002-11-29 2004-06-02 Aventis Behring Gesellschaft mit beschränkter Haftung Modified cDNA factor VIII and its derivates
EP1454916A1 (en) * 2002-11-29 2004-09-08 ZLB Behring GmbH Modified cDNA factor VIII and its derivatives
EP1502921A1 (en) * 2003-07-29 2005-02-02 ZLB Behring GmbH Recombinant mutated human factor VIII (FVIII) with improved stability
US7211559B2 (en) 2003-10-31 2007-05-01 University Of Maryland, Baltimore Factor VIII compositions and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006999A1 (en) * 1990-10-17 1992-04-30 The Scripps Research Institute Therapeutic fragments of von willebrand factor
AU607927B2 (en) * 1986-06-24 1991-03-21 Nordisk Gentofte A/S A process for producing a coagulation active complex of factor viii fragments
EP0294910B1 (en) * 1987-06-12 1996-09-11 Immuno Ag Novel proteins with factor VIII activity, process for their preparation using genetically engineered cells and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
WO1995018827A1 (en) 1995-07-13

Similar Documents

Publication Publication Date Title
AU2070795A (en) 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives
AU4000997A (en) Triazolyl derivatives
AU4665596A (en) Pyrazolylbenzoyl derivatives
AU1735497A (en) Sulfonylureidopyrazole derivatives
AU1195897A (en) Heteroarylcarboxamide derivatives
AU4086296A (en) Indolepiperidine derivatives
AU4875296A (en) Isoxazolyl-benzoyl derivatives
AU3867997A (en) Chromene-3-carboxylate derivatives
AU7738098A (en) Novel tetrahydrobenzindolone derivatives
AU2956097A (en) Alkylaminobenzothiazole and -benzoxazole derivatives
AU5763596A (en) 2-ureido-benzamide derivatives
AU2485595A (en) 1-Pyridyltetrazolinone derivatives
EP1008579A3 (en) Cyclopentenebutanol derivatives
AU6191796A (en) Sulfonyl- or sulfinylbenzoylguanidine derivatives
AU4962097A (en) 2-methoxyphenylpiperazine derivatives
AU1793197A (en) Pyrazole-4-yl-hetaroyl derivatives
AU3994095A (en) Thrombocytotic factor
AU5052296A (en) 4-indolylpiperazinyl derivatives
AU4547796A (en) Hexahydropyrazinoquinoline derivatives
AU4117396A (en) Morpholinoethylamide derivatives
AU1382595A (en) Factor viii derivatives
AU689566B2 (en) DC-89 derivatives
AU3685097A (en) N-benzylazolium derivatives
AU4211296A (en) 4-aminobenzoylguanidine derivatives
AU3619695A (en) Thioquinolone derivative